IL33 and neoplasm: Another notable aspect of our study was the use of a reliable preclinical organoid model of EGC combined with scRNA‐seq data and the finding that IL‐33+ endothelial cells can promote angiogenesis and tumor proliferation in EGC by influencing adhesion molecules (PECAM1, CD34, and KRT17).